{
  "id": "nafld_fibrosis_score",
  "title": "NAFLD (Non-Alcoholic Fatty Liver Disease) Fibrosis Score",
  "description": "Estimates amount of scarring in the liver based on various lab tests. Distinguishes between patients with nonalcoholic fatty liver disease who have (F3-F4) and do not have (F0-F2) advanced fibrosis.",
  "category": "gastroenterology",
  "version": "2007",
  "parameters": [
    {
      "name": "age",
      "type": "float",
      "required": true,
      "description": "Patient age in years",
      "validation": {
        "min": 0,
        "max": 120
      },
      "unit": "years"
    },
    {
      "name": "bmi",
      "type": "float",
      "required": true,
      "description": "Body Mass Index calculated as weight(kg) / height(m)²",
      "validation": {
        "min": 10,
        "max": 70
      },
      "unit": "kg/m²"
    },
    {
      "name": "hyperglycemia",
      "type": "string",
      "required": true,
      "description": "Presence of impaired fasting glucose (IFG) or diabetes mellitus",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "ast",
      "type": "float",
      "required": true,
      "description": "Aspartate aminotransferase (AST) level",
      "validation": {
        "min": 1,
        "max": 2000
      },
      "unit": "IU/L"
    },
    {
      "name": "alt",
      "type": "float",
      "required": true,
      "description": "Alanine aminotransferase (ALT) level",
      "validation": {
        "min": 1,
        "max": 2000
      },
      "unit": "IU/L"
    },
    {
      "name": "platelet_count",
      "type": "float",
      "required": true,
      "description": "Platelet count",
      "validation": {
        "min": 10,
        "max": 800
      },
      "unit": "×10⁹/L"
    },
    {
      "name": "albumin",
      "type": "float",
      "required": true,
      "description": "Serum albumin level",
      "validation": {
        "min": 1.0,
        "max": 6.0
      },
      "unit": "g/dL"
    }
  ],
  "result": {
    "name": "nafld_fibrosis_score",
    "type": "float",
    "unit": "points",
    "description": "NAFLD Fibrosis Score value"
  },
  "interpretation": {
    "ranges": [
      {
        "min": -10.0,
        "max": -1.455,
        "stage": "F0-F2",
        "description": "Absence of significant fibrosis",
        "interpretation": "Score < -1.455 is a predictor of absence of significant fibrosis (F0-F2 fibrosis). Negative predictive value of 93% for ruling out advanced fibrosis. These patients have mild to moderate fibrosis and are unlikely to have advanced liver disease."
      },
      {
        "min": -1.455,
        "max": 0.676,
        "stage": "Indeterminate",
        "description": "Indeterminate zone",
        "interpretation": "Score between -1.455 and 0.676 falls in the indeterminate zone. Approximately 30% of patients fall into this range where the score cannot definitively rule in or rule out advanced fibrosis. Additional testing such as liver biopsy, elastography, or other non-invasive markers may be needed."
      },
      {
        "min": 0.676,
        "max": 10.0,
        "stage": "F3-F4",
        "description": "Presence of significant fibrosis",
        "interpretation": "Score > 0.676 is a predictor of presence of significant fibrosis (F3-F4 fibrosis). Positive predictive value of 90% for advanced fibrosis. These patients likely have bridging fibrosis (F3) or cirrhosis (F4) and should be considered for close monitoring and treatment."
      }
    ]
  },
  "references": [
    "Angulo P, Hui JM, Marchesini G, Bugianesi E, George J, Farrell GC, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007 Apr;45(4):846-54. doi: 10.1002/hep.21496.",
    "McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010 Sep;59(9):1265-9. doi: 10.1136/gut.2010.216077."
  ],
  "formula": "NAFLD Score = -1.675 + 0.037 × age (years) + 0.094 × BMI (kg/m²) + 1.13 × hyperglycemia (yes=1, no=0) + 0.99 × AST/ALT ratio - 0.013 × platelet count (×10⁹/L) - 0.66 × albumin (g/dL)",
  "notes": [
    "Fibrosis stages: F0 = absence of fibrosis, F1 = perisinusoidal or periportal fibrosis, F2 = perisinusoidal and portal/periportal fibrosis, F3 = bridging fibrosis, F4 = cirrhosis",
    "The score was developed based on 733 patients with biopsy-proven NAFLD",
    "AUROC for detecting advanced fibrosis was 0.88 (95% CI 0.85-0.92)",
    "Approximately 30% of patients may fall into the indeterminate range requiring additional testing",
    "The score helps reduce the need for liver biopsy by identifying patients likely or unlikely to have advanced fibrosis"
  ]
}